Clinical Trials Directory

Trials / Completed

CompletedNCT06860620

Efficacy of Zinc Supplementation in Maintaining Sustained Remission in Children With Steroid-sensitive Nephrotic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
192 (actual)
Sponsor
Muhammad Aamir Latif · Academic / Other
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

This study aims to fill the gaps by determining the efficacy of zinc supplementation in maintaining sustained remission in children with steroid sensitive nephrotic syndrome (SSNS).

Detailed description

There is a need to ascertain the efficacy of zinc supplementation in maintaining sustained remission in children with SSNS, thereby lowering the number of relapses and disease morbidity. The findings of this study could pave the way for reasonable evidence about the role of zinc supplementation is sustained remission in children with SSNS.

Conditions

Interventions

TypeNameDescription
DRUGZinc supplementation plus standard treatmentchildren were given 5 mg of elemental zinc sulfate as a single daily dose for children less than 4 years of age and 10 mg for children more than 4 years of age for a total duration of 6 months, along with standard therapy.

Timeline

Start date
2024-01-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2025-03-06
Last updated
2025-03-06

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06860620. Inclusion in this directory is not an endorsement.